Trigger Activity More Than Three Years After Left Atrial Linear Ablation Without Pulmonary Vein Isolation in Patients With Atrial Fibrillation
|
|
- Rudolph Pearson
- 5 years ago
- Views:
Transcription
1 Journal of the American College of Cardiology Vol. 46, No. 2, by the American College of Cardiology Foundation ISSN /05/$30.00 Published by Elsevier Inc. doi: /j.jacc Trigger Activity More Than Three Years After Left Atrial Linear Ablation Without Pulmonary Vein Isolation in Patients With Atrial Fibrillation Hildegard Tanner, MD, Gerhard Hindricks, MD, Richard Kobza, MD, Anja Dorszewski, MD, Petra Schirdewahn, MD, Christopher Piorkowski, MD, Jin-Hong Gerds-Li, MD, Hans Kottkamp, MD Leipzig, Germany OBJECTIVES BACKGROUND METHODS RESULTS CONCLUSIONS The aim of this study was to analyze trigger activity in the long-term follow-up after left atrial (LA) linear ablation. Interventional strategies for curative treatment of atrial fibrillation (AF) are targeted at the triggers and/or the maintaining substrate. After substrate modification using nonisolating linear lesions, the activity of triggers is unknown. With the LA linear lesion concept, 129 patients were treated using intraoperative ablation with minimal invasive surgical techniques. Contiguous radiofrequency energy-induced lesion lines involving the mitral annulus and the orifices of the pulmonary veins without isolation were placed under direct vision. After a mean follow-up of years, atrial ectopy, atrial runs, and reoccurrence of AF episodes were analyzed by digital 7-day electrocardiograms in 30 patients. Atrial ectopy was present in all patients. Atrial runs were present in 25 of 30 patients (83%), with a median number of 9 runs per patient/week (range 1 to 321) and a median duration of 1.2 s/run (range 0.7 to 25), without a significant difference in atrial ectopy and atrial runs between patients with former paroxysmal (n 17) or persistent AF (n 13). Overall, 87% of all patients were completely free from AF without antiarrhythmic drugs. A detailed rhythm analysis late after specific LA linear lesion ablation shows that trigger activity remains relatively frequent but short and does not induce AF episodes in most patients. The long-term success rate of this concept is high in patients with paroxysmal or persistent AF. (J Am Coll Cardiol 2005;46:338 43) 2005 by the American College of Cardiology Foundation For curative treatment of atrial fibrillation (AF), the initiating triggers and the perpetuating substrate are the main targets for interventional ablation strategies (1 6). A specific left atrial (LA) linear lesion concept targeting the perpetuation of AF and therefore modifying the substrate was tested using intraoperative ablation with minimally invasive surgical techniques in the Intraoperative Radiofrequency Ablation of Atrial Fibrillation (IRAAF) study (7,8). In that study, contiguous radiofrequency (RF) energyinduced lesion lines involving the mitral annulus (MA) and the orifices of the pulmonary veins (PV) were placed under direct vision to prevent anatomically defined LA re-entrant circuits. No PV isolation, surgical mass reduction, or right atrial lesions were performed. After substrate modification using nonisolating linear lesion lines, the activity of initiating triggers is unknown. Therefore, the aim of the present study was to analyze trigger activity in the IRAAF population, i.e., premature atrial complexes (PAC) and, in particular, atrial runs, and reoccurrence of AF episodes in these patients during longterm follow-up more than three years after the ablation procedure. From the University of Leipzig, Heart Center, Cardiology, Department of Electrophysiology, Leipzig, Germany. Dr. Tanner was supported by a grant from the Swiss Foundation for Pacemaker and Electrophysiology. Manuscript received November 16, 2004; revised manuscript received March 23, 2005, accepted March 29, METHODS Study population. Of 129 patients treated for paroxysmal and persistent AF with intraoperative RF ablation as a primary indication for operation using minimally invasive surgical techniques through a right lateral minithoracotomy, 30 consecutive patients (27 men, 3 women, mean age years) reaching a follow-up of at least 3 years were included in the present analysis (Table 1). Seventeen patients (57%) originally had paroxysmal AF and 13 (43%) persistent AF with an AF history of 8 6 years (range 1 to 25 years). All patients were highly symptomatic before ablation despite multiple antiarrhythmic drug regimens including class I and III antiarrhythmic drugs. All patients with paroxysmal AF had two or more AF episodes per week lasting 12 h. Lone AF was present in 19 patients (64%), 7 (23%) had a history of arterial hypertension, and 4 (13%) had a history of myocarditis and/or pericarditis. No patient had coronary artery disease or valvular heart disease as assessed with coronary angiography or transthoracic or transesophageal echocardiography. Five patients had a total of six ablation procedures before study entry: two patients had conventional ablation of the cavo-tricuspid isthmus because of typical atrial flutter, two patients had Lasso-guided PV isolation with AF recurrence, and one patient had both procedures. The institutional
2 JACC Vol. 46, No. 2, 2005 July 19, 2005: Tanner et al. Trigger Activity Late After Ablation of AF 339 Abbreviations and Acronyms AF atrial fibrillation ECG electrocardiogram IRAAF Intraoperative Radiofrequency Ablation of Atrial Fibrillation LA left atrium/atrial MA mitral annulus PAC premature atrial complex PV pulmonary vein RF radiofrequency Table 1. Clinical Characteristics of the Study Patients (n 30) Age, yrs Men, n (%) 27 (90) AF history, yrs Arterial hypertension, n (%) 7 (23) History of myocarditis/pericarditis, n (%) 4 (13) Coronary artery disease, n (%) 0 (0) Valvular heart disease or CM, n (%) 0 (0) Paroxysmal AF, n (%) 17 (57) Persistent AF, n (%) 13 (43) Lone AF, n (%) 19 (64) Left atrial diameter, mm 43 5 LV ejection fraction, % 60 7 No prior ablation attempt, n (%) 25 (83) Prior AF ablation, n (%) 3 (10) Prior atrial flutter ablation, n (%) 3 (10) Duration of follow-up, yrs AF atrial fibrillation; CM cardiomyopathy; LV left ventricular. Figure 1. Drawing of the left atrium (LA) in a postero-anterior view with the radiofrequency energy-induced left atrial linear lesions (dense black lines) for treatment of atrial fibrillation. The first line extended from the mitral annulus (MA) to the left lower pulmonary vein (LLPV). The second line connected the LLPV and the left upper pulmonary vein (LUPV) orifices. From there, a third line coupled the left and the right pulmonary veins. Then the right upper pulmonary vein (RUPV) and right lower pulmonary vein (RLPV) orifices were connected. Care was taken to advance the tip of the ablation probe only a few millimeters inside the funnel-shaped parts of the pulmonary veins. Finally, the line at the LA roof was connected to the surgical incision to prevent incisional re-entry. The dotted line indicates the LA incision. IVC inferior vena cava; LAA left atrial appendage; SVC superior vena cava. review committee approved the study, and all patients gave written informed consent to the investigational nature of the procedure. Surgical approach and RF catheter ablation. A detailed description of the surgical approach and the ablation technique has been published previously (7,8). Briefly, all patients were operated on a video-assisted minimally invasive surgical approach via a right anterolateral minithoracotomy. The LA was incised parallel to the interatrial groove anterior to the right PVs, allowing access to the MA as well as exposure of the orifices of the PVs. Radiofrequency alternating current (500 khz, modified HAT 200S; Osypka GmbH, Grenzach-Wyhlen, Germany) was delivered in a unipolar mode between the 10-mm T-shaped tip electrode of a specially designed ablation probe (Osypka GmbH) and a cm external backplate electrode. A drawing of the LA with the RF energy-induced LA linear lesions is given in Figure 1. The first lesion line extended from the left inferior aspect of the MA to the left PVs. The second line connected the left lower and upper PV orifices. From there, a third line coupled the left and right upper PVs. Then the right upper and lower PV orifices were connected. Finally, the line at the LA roof was connected to the surgical incision to prevent incisional re-entry. Postoperative management and follow-up. Daily 12-lead electrocardiograms (ECGs) and two 24-h ECGs were performed within the first 10 postoperative days. In case of early recurrences of AF, electrical cardioversion and institution of an antiarrhythmic drug treatment (class Ic or amiodarone) were followed. According to the study protocol, antiarrhythmic drug treatment was withdrawn three months after the operation. All patients were seen in the outpatient clinic at six weeks, three months, six months, one year, two years, and three years after the procedure. A 12-lead ECG, 24-h ECG, and echocardiography were performed in all patients during each follow-up visit. In two-thirds of the patients with persistent and in one-third of the patients with paroxysmal AF, transient recurrences of AF were observed in the early postoperative period (8). However, these early relapses of AF directly after operation did not predict long-term treatment outcome, and freedom from AF after 12 months measured 90%. For the present study, in all patients reaching a follow-up of at least three years, a continuous digital seven-day ECG (Lifecard CF; DelmarReynolds Medical, Inc., Irvine, California) was recorded. One patient was excluded from analysis because of the presence of a dual-chamber pacemaker because of sick sinus syndrome with permanent atrial stimulation. Detailed rhythm analysis was done by the means of the seven-day ECG recordings. As surrogate for trigger activity, PAC and atrial runs (3 beats up to 30 s) were counted. Frequent PACs were defined as 100 PAC per 7-day ECG. The duration and number of
3 340 Tanner et al. JACC Vol. 46, No. 2, 2005 Trigger Activity Late After Ablation of AF July 19, 2005: Figure 2. Typical examples of electrocardiogram recordings of rare and frequent premature atrial complexes (A and B), short and long atrial runs (C and D), and atrial fibrillation (E) in five different patients. ventricular contractions resulting from atrial runs were measured. In addition, a quantitative analysis of all recurrent AF episodes (episode lasting more than 30 s) was performed. The analysis of the recordings was done by a single electrophysiologist. The counting was done manually in the first 10 patients because an automatic counting was not possible. Thereafter, the data of these patients were exported to analysis software (Pathfinder, DelmarReynolds Medical Inc., Irvine, California). After analysis by this software, all premature complexes and atrial runs were checked again. There was no difference in manually counting and using the software with respect to the number of atrial runs, and the difference with respect to premature atrial contraction was 5% and not significant. Therefore, the remaining 20 patients received software-assisted counting with manual correction. Patients were equipped with a symptom log and instructed on how to document duration, quality, and severity of symptoms during the ECG recording and medical treatment (i.e., antiarryhthmic drugs, beta-blockade, and oral anticoagulation therapy). The symptoms (palpitation, dyspnea, dizziness, and chest pain as surrogate of AF) were qualitatively scored in the symptom log as none, minimal, mild, moderate, or severe. Statistical analysis. Continuous variables were expressed as mean SD or as median and range when variables were not normally distributed. RESULTS After a mean follow-up of years (range 3.0 to 4.3 years), ECG hours per patient (range 131 to 168 h) were recorded and analyzed. Typical examples of ECG recordings of rare and frequent PACs, short and long atrial runs, and AF in five different patients are given in Figure 2. Overall, 29 of 30 patients (97%) did not receive any antiarrhythmic drugs; 1 patient was treated with amiodarone. Twenty patients (67%) received beta-blockers and 11 patients (37%) had treatment with an angiotensinconverting enzyme inhibitor. Patients were treated with beta-blockers because of arterial hypertension (n 7), rate control in case of AF (n 2), and mild symptoms of PACs and atrial runs (n 11). No other rate-controlling medication was used. Two patients (7%) with recurrent AF received oral anticoagulation therapy; nine patients (30%) had treatment with aspirin. Quality of recordings. The intention to monitor was seven days for all patients. Therefore, the overall duration of the assessed single-lead ECG recordings was 5,040 h. From the intended 5,040 h of recordings, 4,857 h (96%) were available for analysis. More than 3% of the missing data were because of part-time removal of the device by the patient. Less than 1% of the recordings were excluded from analysis because of artifacts. Patients were equipped with additional surface electrodes in case of insufficient skin contact. In this
4 JACC Vol. 46, No. 2, 2005 July 19, 2005: Tanner et al. Trigger Activity Late After Ablation of AF 341 Figure 3. Presence of atrial (AT) runs, frequent ( 100) premature atrial complexes (PAC), and PAC in all patients, and in those with former paroxysmal (n 17) and persistent (n 13) atrial fibrillation (AF). Ruled bars all patients; dotted bars paroxysmal AF; black bars persistent AF. case, the patients were alerted by the device. Therefore, the overall recording quality was excellent. PAC and atrial runs. Premature atrial complexes were present in all patients over a wide range (median 240, range 10 to 62,751) (Fig. 3). Premature atrial complexes in patients with former paroxysmal AF (median 188, range 11 to 32,568) and former persistent AF (median 726, range 10 to 62,751) were comparable. More than 100 PACs per 7-day ECG were found in 21 patients (70%). Frequent PACs in patients with former paroxysmal AF (65%) and in those with former persistent AF (77%) were comparable. Atrial runs were found in 83% of all patients (n 25). Patients with former paroxysmal AF had slightly more atrial runs (n 15, 88%) than patients with former persistent AF (n 10, 77%). The median duration of ventricular contractions resulting from atrial runs measured 1.2 s/run (range 0.7 to 25 s) with a median number of 4 beats (range 3 to 56 beats) per atrial run. Reoccurrence of AF. Overall, 26 of 30 patients (87%) were completely free from AF and 4 patients (13%) had paroxysmal episodes of AF. Two of them were asymptomatic. Three of these patients had former persistent AF, later presenting with paroxysmal AF, and one patient had former paroxysmal AF. No patient presented with persistent AF. Freedom from AF in patients with former paroxysmal AF was 94% (one patient with antiarrhythmic drug treatment) and 77% in patients with former persistent AF (no patients with antiarrhythmic drug treatment) (Fig. 4). Directly after the procedure, freedom from AF measured 53%, after 6 months 97%, after 1 year 100%, after 2 years 100% as assessed with conventional 24-h ECG, and after 3 years using 7-day ECGs 87% (Fig. 5). Altogether, 29 AF episodes were found in the 4 patients with recurrent paroxysmal AF. Given the overall number of 1,017 atrial runs, 2.8% of these runs resulted in AF (defined as lasting 30 s). Twenty-six of 29 AF episodes (90%) lasted 2 h, one AF episode (3%) lasted between 2 and 24 h, and only 2 AF episodes (7%) lasted more than 24 h. In patients with former paroxysmal AF, no episode lasted more than 2 h. No episode with atrial flutter was detected. The definition of recurrent AF was arbitrarily set to 30 s. Figure 4. Freedom from atrial fibrillation (AF) in all patients and in those with former paroxysmal (n 17) and persistent (n 13) AF after years. We decided to take this widely used definition to allow comparison with other AF studies. If the definition of AF is changed to 15 s, only one additional patient had recurrence of AF because the vast majority of atrial runs were of short duration (median duration 1.2 s). Therefore, results would not differ substantially if this shorter duration had been chosen. PAC and atrial runs in patients with and without reoccurrence of AF. Comparing patients without (n 26) and patients with AF recurrences (n 4, 3 with former persistent AF), PACs were more frequent in patients with AF recurrences: median 13,560 (range 726 to 62,751) versus median 199 (range 10 to 32,568). Accordingly, patients with AF recurrences had more atrial runs: median 131 (range 7 to 321) versus median 7 (range 0 to 83) in patients without AF recurrence. Symptoms. Patients with only PACs and atrial runs scored their symptoms as none in 68% (n 17), as minimal in 24% (n 6), and as mild in 8% (n 2). No patient had moderate or severe symptoms. One patient did not state his symptoms on the symptom log. Patients with AF recurrence (n 4) scored their symptoms as none (n 1), mild (n 1), moderate (n 1), and severe (n 1). Sixty-one percent of all asymptomatic patients were treated with beta- Figure 5. Freedom from atrial fibrillation (AF) after the procedure and after 6 months and 1, 2, and 3 years, respectively. Follow-up was done by continuous monitoring during the first week after ablation, conventional 24-h electrocardiogram (ECG) after 6 months and 1 and 2 years, and 7-day ECG after 3 years.
5 342 Tanner et al. JACC Vol. 46, No. 2, 2005 Trigger Activity Late After Ablation of AF July 19, 2005: blockers, whereas 73% of all symptomatic patients (minimal to severe symptoms) had beta-blocker treatment. DISCUSSION Main findings. The present study shows, for the first time, that trigger activity late after specific linear LA ablation remains present in the majority of patients. Premature atrial complexes were found in all patients. Atrial runs (3 beats up to 30 s) were frequent but of short duration (median 1.2 s). Role of trigger activity after catheter ablation. For curative treatment of AF, the initiating triggers and the perpetuating substrate are the main targets for interventional ablation strategies (1 6). The majority of foci triggering AF originate from myocardial sleeves within the PVs. Additionally, foci were found in the funnel-shaped transition zone and, in some cases, also in areas of the left or right atrium unrelated to the PVs (1,9 11). Electrophysiologic studies in patients undergoing repeat PV isolation because of AF recurrences showed that in the majority of cases reinitiating triggers originate from previously isolated PVs, which have regained conduction to the LA (12,13). To date, no reports on the presence of ectopic activity and atrial runs after successful PV isolation targeting trigger elimination are present during long-term follow-up. Accordingly, it is unknown whether trigger activity remains present in the long-term follow-up after LA linear ablation targeting at the perpetuation of AF without PV isolation. The prevention of the perpetuating re-entrant circuits as substrate modification is the alternative interventional treatment strategy to cure AF. In the IRAAF study, a specific LA linear lesion concept targeting at the prevention of anatomic LA re-entry was tested using intraoperative ablation with minimally invasive surgical techniques (7,8). In that study, contiguous RF energy-induced lesion lines involving the MA and the orifices of the PVs were placed under direct vision to prevent anatomically defined LA re-entrant circuits. The present study analyzed the occurrence and role of trigger activity late after substrate modification in patients with paroxysmal and persistent AF treated with the IRAAF concept. Continuous digital seven-day ECGs were used for follow-up. With this approach, significantly more AF episodes could be detected compared with conventional 24-h ECG in a recent study using percutaneous ablation (14). The quantitative analysis of atrial ectopy and in particular atrial runs, defined as runs of atrial tachycardia/ nonsustained AF episodes from 3 beats up to 30 s, showed the presence of PAC in all patients and frequent PAC and atrial runs in the majority of patients. The median duration of ventricular contractions resulting from atrial runs was low, measuring 1.2 s/run with a median number of 4 ventricular contractions per atrial run. Whether all PACs and atrial runs represent potential triggers for induction of AF remains unproven, because their origin was not determined invasively and their role in inducing AF before ablation cannot be quantified. However, despite the high prevalence of atrial ectopy, the rate of AF recurrence was low (4 of 30 patients, 13%) both in patients with paroxysmal AF (1 of 17 patients, 6%) and in those with former persistent AF (3 of 13 patients, 23%). This implies that with this strategy aiming at the perpetuation of AF, the substrate cannot sustain AF in the majority of patients. Study limitations. Atrial ectopy was found in all patients, and atrial runs were found in 83% of patients. However, the high use of beta-blockers in our study cohort may have influenced the amount and occurrence of PACs and atrial runs, which might have been even higher without this treatment. In addition, beta-blockade may have influenced the high percentage of asymptomatic or only mildly symptomatic patients. Measurement of trigger activity in one-lead surface ECG is a surrogate of trigger activity measured invasively, and the origin within the atria cannot be determined. However, trigger activity is likely underestimated by seven-day ECG because of AV block and hidden P waves in the T waves and ST-segment, and because of non-conducted ectopic activity from the foci to atrial musculature. Moreover, trigger activity has a wide time-dependent intra-individual and interindividual variability, which underlines the usefulness of long-term recordings such as the continuous seven-day ECG recordings that were used in the present study. Analysis with larger sample size would be desirable to confirm our results. Reprint requests and correspondence: Dr. Hildegard Tanner, University of Leipzig, Heart Center, Cardiology, Dept. of Electrophysiology, Struempellstrasse 39, D Leipzig, Germany. hilditanner@pop.agri.ch. REFERENCES 1. Haissaguerre M, Jais P, Shah DC, et al. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med 1998;339: Ernst S, Schluter M, Ouyang F, et al. Modification of the substrate for maintenance of idiopathic human atrial fibrillation: efficacy of radiofrequency ablation using nonfluoroscopic catheter guidance. Circulation 1999;100: Jais P, Shah DC, Haissaguerre M, et al. Efficacy and safety of septal and left-atrial linear ablation for atrial fibrillation. Am J Cardiol 1999;84:139R 46R. 4. Pappone C, Oreto G, Rosanio S, et al. Atrial electroanatomic remodeling after circumferential radiofrequency pulmonary vein ablation: efficacy of an anatomic approach in a large cohort of patients with atrial fibrillation. Circulation 2001;104: Oral H, Scharf C, Chugh A, et al. Catheter ablation for paroxysmal atrial fibrillation: segmental pulmonary vein ostial ablation versus left atrial ablation. Circulation 2003;108: Pappone C, Rosanio S, Augello G, et al. Mortality, morbidity, and quality of life after circumferential pulmonary vein ablation for atrial fibrillation: outcomes from a controlled nonrandomized long-term study. J Am Coll Cardiol 2003;42: Kottkamp H, Hindricks G, Hammel D, et al. Intraoperative radiofrequency ablation of chronic atrial fibrillation: a left atrial curative approach by elimination of anatomic anchor reentrant circuits. J Cardiovasc Electrophysiol 1999;10: Kottkamp H, Hindricks G, Autschbach R, et al. Specific linear left atrial lesions in atrial fibrillation: intraoperative radiofrequency abla-
6 JACC Vol. 46, No. 2, 2005 July 19, 2005: Tanner et al. Trigger Activity Late After Ablation of AF 343 tion using minimally invasive surgical techniques. J Am Coll Cardiol 2002;40: Chen SA, Hsieh MH, Tai CT, et al. Initiation of atrial fibrillation by ectopic beats originating from the pulmonary veins: electrophysiological characteristics, pharmacological responses, and effects of radiofrequency ablation. Circulation 1999;100: Goya M, Ouyang F, Ernst S, et al. Electroanatomic mapping and catheter ablation of breakthroughs from the right atrium to the superior vena cava in patients with atrial fibrillation. Circulation 2002;106: Shah D, Haissaguerre M, Jais P, Hocini M. Nonpulmonary vein foci: do they exist? Pacing Clin Electrophysiol 2003;26: Gerstenfeld EP, Callans DJ, Dixit S, Zado E, Marchlinski FE. Incidence and location of focal atrial fibrillation triggers in patients undergoing repeat pulmonary vein isolation: implications for ablation strategies. J Cardiovasc Electrophysiol 2003;14: Haissaguerre M, Shah DC, Jais P, et al. Electrophysiological breakthroughs from the left atrium to the pulmonary veins. Circulation 2000;102: Kottkamp H, Tanner H, Kobza R, et al. Time courses and quantitative analysis of atrial fibrillation episode number and duration after circular plus linear left atrial lesions. Trigger elimination or substrate modification: early or delayed cure? J Am Coll Cardiol 2004;44:
Specific Linear Left Atrial Lesions in Atrial Fibrillation Intraoperative Radiofrequency Ablation Using Minimally Invasive Surgical Techniques
Journal of the American College of Cardiology Vol. 40, No. 3, 2002 2002 by the American College of Cardiology Foundation ISSN 0735-1097/02/$22.00 Published by Elsevier Science Inc. PII S0735-1097(02)01993-9
More informationThe pulmonary veins have been demonstrated to often
Pulmonary Vein Isolation for Paroxysmal and Persistent Atrial Fibrillation Hakan Oral, MD; Bradley P. Knight, MD; Hiroshi Tada, MD; Mehmet Özaydın, MD; Aman Chugh, MD; Sohail Hassan, MD; Christoph Scharf,
More informationMechanism of Immediate Recurrences of Atrial Fibrillation After Restoration of Sinus Rhythm
Mechanism of Immediate Recurrences of Atrial Fibrillation After Restoration of Sinus Rhythm AMAN CHUGH, MEHMET OZAYDIN, CHRISTOPH SCHARF, STEVE W.K. LAI, BURR HALL, PETER CHEUNG, FRANK PELOSI, JR, BRADLEY
More information480 April 2004 PACE, Vol. 27
Incremental Value of Isolating the Right Inferior Pulmonary Vein During Pulmonary Vein Isolation Procedures in Patients With Paroxysmal Atrial Fibrillation HAKAN ORAL, AMAN CHUGH, CHRISTOPH SCHARF, BURR
More informationAF Today: W. For the majority of patients with atrial. are the Options? Chris Case
AF Today: W hat are the Options? Management strategies for patients with atrial fibrillation should depend on the individual patient. Treatment with medications seems adequate for most patients with atrial
More informationAF :RHYTHM CONTROL BY DR-MOHAMMED SALAH ASSISSTANT LECTURER CARDIOLOGY DEPARTMENT
AF :RHYTHM CONTROL BY DR-MOHAMMED SALAH ASSISSTANT LECTURER CARDIOLOGY DEPARTMENT 5-2014 Atrial Fibrillation therapeutic Approach Rhythm Control Thromboembolism Prevention: Recommendations Direct-Current
More informationAF ABLATION Concepts and Techniques
AF ABLATION Concepts and Techniques Antony F Chu, M.D. Director of Complex Ablation Arrhythmia Services Section Division of Cardiology at the Rhode Island and Miriam Hospital HIGHLIGHTS The main indications
More informationAtrial Fibrillation: Classification and Electrophysiology. Saverio Iacopino, MD, FACC, FESC
Atrial Fibrillation: Classification and Electrophysiology Saverio Iacopino, MD, FACC, FESC Sinus Rythm Afib (first episode) AFib Paroxistic AFib Spontaneous conversion Permanent AFib Recurrence Sinus Rythm
More informationArrhythmia/Electrophysiology
Arrhythmia/Electrophysiology Perception of Atrial Fibrillation Before and After Radiofrequency Catheter Ablation Relevance of Asymptomatic Arrhythmia Recurrence Gerhard Hindricks, MD; Christopher Piorkowski,
More informationElectrical isolation of the pulmonary veins (PVs) to treat
Mechanisms of Organized Left Atrial Tachycardias Occurring After Pulmonary Vein Isolation Edward P. Gerstenfeld, MD; David J. Callans, MD; Sanjay Dixit, MD; Andrea M. Russo, MD; Hemal Nayak, MD; David
More informationCatheter Ablation: Atrial fibrillation (AF) is the most common. Another Option for AF FAQ. Who performs ablation for treatment of AF?
: Another Option for AF Atrial fibrillation (AF) is a highly common cardiac arrhythmia and a major risk factor for stroke. In this article, Dr. Khan and Dr. Skanes detail how catheter ablation significantly
More informationCircumferential Pulmonary-Vein Ablation for Chronic Atrial Fibrillation
The new england journal of medicine original article Circumferential Pulmonary-Vein Ablation for Chronic Atrial Fibrillation Hakan Oral, M.D., Carlo Pappone, M.D., Aman Chugh, M.D., Eric Good, D.O., Frank
More informationSince pulmonary veins (PVs) have
Case Report Hellenic J Cardiol 2011; 52: 371-376 Left Atrial-Pulmonary Vein Reentrant Tachycardia Following Pulmonary Vein Isolation Dionyssios Leftheriotis, Feifan Ouyang, Karl-Heinz Kuck II. Med. Abteilung,
More informationCatheter-Induced Linear Lesions in the Left Atrium in Patients With Atrial Fibrillation An Electroanatomic Study
Journal of the American College of Cardiology Vol. 42, No. 7, 2003 2003 by the American College of Cardiology Foundation ISSN 0735-1097/03/$30.00 Published by Elsevier Inc. doi:10.1016/s0735-1097(03)00940-9
More informationIs cardioversion old hat? What is new in interventional treatment of AF symptoms?
Is cardioversion old hat? What is new in interventional treatment of AF symptoms? Joseph de Bono Consultant Electrophysiologist University Hospitals Birmingham Atrial Fibrillation (AF) Affects 2% of the
More informationElectrophysiologic Properties of Pulmonary Veins Assessed Using a Multielectrode Basket Catheter
Journal of the American College of Cardiology Vol. 43, No. 12, 2004 2004 by the American College of Cardiology Foundation ISSN 0735-1097/04/$30.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2004.01.051
More informationAF ablation Penn experience. Optimal approach to the ablation of PAF: Importance of identifying triggers 9/25/2009
Optimal approach to the ablation of PAF: Importance of identifying triggers David J. Callans, MD University of Pennsylvania School of Medicine AF ablation Penn experience Antral (circumferential) PV ablation
More informationAnkara, Turkey 2 Department of Cardiology, Division of Arrhythmia and Electrophysiology, Yuksek Ihtisas
258 Case Report Electroanatomic Mapping-Guided Radiofrequency Ablation of Adenosine Sensitive Incessant Focal Atrial Tachycardia Originating from the Non-Coronary Aortic Cusp in a Child Serhat Koca, MD
More informationCatheter ablation of atrial macro re-entrant Tachycardia - How to use 3D entrainment mapping -
Catheter ablation of atrial macro re-entrant Tachycardia - How to use 3D entrainment mapping - M. Esato, Y. Chun, G. Hindricks Kyoto Ijinkai Takeda Hosptial, Department of Arrhythmia, Japan Kyoto Koseikai
More informationCharacteristics of Rapid Rhythms Recorded Within Pulmonary Veins During Atrial Fibrillation
Characteristics of Rapid Rhythms Recorded Within Pulmonary Veins During Atrial Fibrillation HIROSHI TADA, MEHMET ÖZAYDIN, HAKAN ORAL, BRADLEY P. KNIGHT, AMAN CHUGH, CHRISTOPH SCHARF, FRANK PELOSI, Jr.,
More informationRadiofrequency ablation for atrial fibrillation
European Heart Journal Supplements (2003) 5 (Supplement H), H34 H39 Radiofrequency ablation for atrial fibrillation P. Jaïs 1, D.C. Shah 2, M. Hocini 1, L. Macle 1, K. J. Choi 1, M. Haïssaguerre 1 and
More information2004 3 32 3 Chin J Cardiol, March 2004, Vol. 32 No. 3 211 4 ( ) 4 (HRA) (CS), 10 (Lasso ),, 4 (3 ) (1 ), 118,3,1, 417, ; ; The electrophysiological characteristics and ablation treatment of patients with
More informationReentry in a Pulmonary Vein as a Possible Mechanism of Focal Atrial Fibrillation
824 Reentry in a Pulmonary Vein as a Possible Mechanism of Focal Atrial Fibrillation BERNARD BELHASSEN, M.D., AHARON GLICK, M.D., and SAMI VISKIN, M.D. From the Department of Cardiology, Tel-Aviv Sourasky
More informationAF and arrhythmia management. Dr Rhys Beynon Consultant Cardiologist and Electrophysiologist University Hospital of North Staffordshire
AF and arrhythmia management Dr Rhys Beynon Consultant Cardiologist and Electrophysiologist University Hospital of North Staffordshire Atrial fibrillation Paroxysmal AF recurrent AF (>2 episodes) that
More informationCatheter Ablation of Atrial Fibrillation
HOSPITAL CHRONICLES 2008, 3(1): 29 33 Review Catheter Ablation of Atrial Fibrillation Josef Kautzner, MD, PhD Department of Cardiology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
More informationWhat s new in my specialty?
What s new in my specialty? Jon Melman, MD Heart Rhythm Specialists McKay-Dee Hospital some would say some would say my specialty 1 some would say my specialty First pacemaker 1958 some would say my specialty
More informationClinical Value of Noninducibility by High-Dose Isoproterenol Versus Rapid Atrial Pacing After Catheter Ablation of Paroxysmal Atrial Fibrillation
13 Clinical Value of Noninducibility by High-Dose Isoproterenol Versus Rapid Atrial Pacing After Catheter Ablation of Paroxysmal Atrial Fibrillation THOMAS CRAWFORD, M.D., AMAN CHUGH, M.D., ERIC GOOD,
More informationAblation of long-standing AF. Is it wise to pursue it?
Ablation of long-standing AF. Is it wise to pursue it? Carlo Pappone, MD and Vincenzo Santinelli, MD From: Department of Arrhythmology,GVM Care and Research, Cotignola, Ravenna, ITALY Address for correspondence:
More informationIntegration of CT and fluoroscopy images in the ablative treatment of atrial fibrillation
Clinical applications Integration of CT and fluoroscopy images in the ablative treatment of atrial fibrillation C. Kriatselis M. Tang M. Roser J-H. erds-li E. leck Department of Internal Medicine/Cardiology,
More informationAtrial Fibrillation: Electrophysiological Mechanisms and the Results of Interventional Therapy
Vol. 8, No. 3, September 2003 185 Atrial Fibrillation: Electrophysiological Mechanisms and the Results of Interventional Therapy A.SH. REVISHVILI Bakoulev Research Centre for Cardiovascular Surgery, Russian
More informationA New Approach for Catheter Ablation of Atrial Fibrillation: Mapping of the Electrophysiologic Substrate
Journal of the American College of Cardiology Vol. 43, No. 11, 2004 2004 by the American College of Cardiology Foundation ISSN 0735-1097/04/$30.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2003.12.054
More informationEHRA Accreditation Exam - Sample MCQs Invasive cardiac electrophysiology
EHRA Accreditation Exam - Sample MCQs Invasive cardiac electrophysiology Dear EHRA Member, Dear Colleague, As you know, the EHRA Accreditation Process is becoming increasingly recognised as an important
More informationAtrial fibrillation, Sick sinus syndrome, Sinus pause, Pulmonary vein isola- tion
Case Reports Pulmonary Vein Isolation for Atrial Fibrillation in Patients With Paroxysmal Atrial Fibrillation and Prolonged Sinus Pause Kimie OHKUBO, 1 MD, Ichiro WATANABE, 1 MD, Yasuo OKUMURA, 1 MD, Sonoko
More informationManagement strategies for atrial fibrillation Thursday, 20 October :27
ALTHOUGH anyone who has had to run up a flight of steps or has had a frightening experience is quite familiar with a racing heartbeat, for the more than 2 million Americans who suffer from atrial fibrillation
More informationNew Parameter to Predict Recurrence of Paroxysmal Atrial Fibrillation after Pulmonary Vein Isolation by the P-Wave Signal-Averaged Electrocardiogram
Showa Univ J Med Sci 29 2, 141 150, June 2017 Original New Parameter to Predict Recurrence of Paroxysmal Atrial Fibrillation after Pulmonary Vein Isolation by the P-Wave Signal-Averaged Electrocardiogram
More informationCase Report. Sumito Narita MD 1;3, Takeshi Tsuchiya MD, PhD 1, Hiroya Ushinohama MD, PhD 2, Shin-ichi Ando MD, PhD 3
Case Report Identification and Radiofrequency Catheter Ablation of a Nonsustained Atrial Tachycardia at the Septal Mitral Annulus with the Use of a Noncontact Mapping System: A Case Report Sumito Narita
More informationTreating Atrial Fibrillation. Richard Schilling. St Bartholomew's Hospital, Queen Mary s University of London
Treating Atrial Fibrillation Richard Schilling St Bartholomew's Hospital, Queen Mary s University of London AF burden Framingham Lifetime risk of developing AF = 25% Mortality: SMR =1.9 1.5 NHS audit 1%
More informationInvasive and Medical Treatments for Atrial Fibrillation. Thomas J Dresing, MD Section of Electrophysiology and Pacing Cleveland Clinic
Invasive and Medical Treatments for Thomas J Dresing, MD Section of Electrophysiology and Pacing Cleveland Clinic Disclosures Fellow s advisory panel for St Jude Medical Speaking honoraria from: Boston
More informationTime to recurrence of atrial fibrillation influences outcome following catheter ablation
Time to recurrence of atrial fibrillation influences outcome following catheter ablation Larraitz Gaztañaga, MD, David S. Frankel, MD, Maria Kohari, MD, Lavanya Kondapalli, MD, Erica S. Zado, PA-C, FHRS,
More informationΔιαδερμική Θεραπεία Κολπικής Μαρμαρυγής: Αποτελέσματα και Δεδομένα στην Ελλάδα
Διαδερμική Θεραπεία Κολπικής Μαρμαρυγής: Αποτελέσματα και Δεδομένα στην Ελλάδα Eleftherios M. Kallergis MD, PhD, FESC Cardiology Department Heraklion University Hospital ΠΑΝΕΛΛΗΝΙΑ ΣΕΜΙΝΑΡΙΑ ΟΜΑΔΩΝ ΕΡΓΑΣΙΑΣ
More informationNoninducibility of Atrial Fibrillation as an End Point of Left Atrial Circumferential Ablation for Paroxysmal Atrial Fibrillation A Randomized Study
Noninducibility of Atrial Fibrillation as an End Point of Left Atrial Circumferential Ablation for Paroxysmal Atrial Fibrillation A Randomized Study Hakan Oral, MD; Aman Chugh, MD; Kristina Lemola, MD;
More informationAtrial fibrillation (AF) is the most common arrhythmia in
Distinctive Electrophysiological Properties of Pulmonary Veins in Patients With Atrial Fibrillation Pierre Jaïs, MD; Mélèze Hocini, MD; Laurent Macle, MD; Kee-Joon Choi, MD; Isabel Deisenhofer, MD; Rukshen
More informationRepeat procedures: the best approach
ESC Stockholm 2010 Repeat procedures: the best approach Gerhard Hindricks, MD University Leipzig - Heart Center - Dept. of Electrophysiology Leipzig, Germany Presenter Disclosure Information Gerhard Hindricks
More informationJournal of the American College of Cardiology Vol. 38, No. 5, by the American College of Cardiology ISSN /01/$20.
Journal of the American College of Cardiology Vol. 38, No. 5, 2001 2001 by the American College of Cardiology ISSN 0735-1097/01/$20.00 Published by Elsevier Science Inc. PII S0735-1097(01)01578-9 Morphological
More informationAtrial fibrillation (AF) is the most common sustained
Chronic Atrial Fibrillation in Patients With Rheumatic Heart Disease Mapping and Radiofrequency Ablation of Flutter Circuits Seen at Initiation After Cardioversion Mohan Nair, MD; Prasad Shah, MD; Ravinder
More informationThe impact of hypertension on the electromechanical properties and outcome of catheter ablation in atrial fibrillation patients
Original Article The impact of hypertension on the electromechanical properties and outcome of catheter ablation in atrial fibrillation patients Tao Wang 1, Yun-Long Xia 1, Shu-Long Zhang 1, Lian-Jun Gao
More informationArrhythmias and Heart Failure Dr Chris Lang Consultant Cardiologist and Electrophysiologist Royal Infirmary of Edinburgh
Arrhythmias and Heart Failure Dr Chris Lang Consultant Cardiologist and Electrophysiologist Royal Infirmary of Edinburgh Arrhythmias and Heart Failure Ventricular Supraventricular VT/VF Primary prevention
More informationAtrial ectopic beats within the pulmonary veins (PVs) are
Phased-Array Intracardiac Echocardiography Monitoring During Pulmonary Vein Isolation in Patients With Atrial Fibrillation Impact on Outcome and Complications Nassir F. Marrouche, MD; David O. Martin,
More informationTime to Cardioversion of Recurrent Atrial Arrhythmias After Catheter Ablation of Atrial Fibrillation and Long-Term Clinical Outcome
Time to Cardioversion of Recurrent Atrial Arrhythmias After Catheter Ablation of Atrial Fibrillation and Long-Term Clinical Outcome TIMIR S. BAMAN, M.D., SANJAYA K. GUPTA, M.D., SREEDHAR R. BILLAKANTY,
More informationPediatrics. Arrhythmias in Children: Bradycardia and Tachycardia Diagnosis and Treatment. Overview
Pediatrics Arrhythmias in Children: Bradycardia and Tachycardia Diagnosis and Treatment See online here The most common form of cardiac arrhythmia in children is sinus tachycardia which can be caused by
More informationAF in the ER: Common Scenarios CASE 1. Fast facts. Diagnosis. Management
AF in the ER: Common Scenarios Atrial fibrillation is a common problem with a wide spectrum of presentations. Below are five common emergency room scenarios and the management strategies for each. Evan
More informationTHE AFIB REPORT. Your Premier Information Resource for Lone Atrial Fibrillation! NUMBER 115 DECEMBER 2011/JANUARY th YEAR
THE AFIB REPORT Your Premier Information Resource for Lone Atrial Fibrillation! NUMBER 115 DECEMBER 2011/JANUARY 2012 11 th YEAR Welcome to our 7 th ablation/maze survey. Previous surveys dealt mainly
More informationThe characteristic anatomic distribution for focal atrial
Electrophysiological and Electrocardiographic Characteristics of Focal Atrial Tachycardia Originating From the Pulmonary Veins Acute and Long-Term Outcomes of Radiofrequency Ablation Peter M. Kistler,
More informationTime Course for Resolution of Left Atrial Appendage Stunning After Catheter Ablation of Chronic Atrial Flutter
Journal of the American College of Cardiology Vol. 41, No. 12, 2003 2003 by the American College of Cardiology Foundation ISSN 0735-1097/03/$30.00 Published by Elsevier Inc. doi:10.1016/s0735-1097(03)00496-0
More informationRadiofrequency Catheter Ablation for Atrial Fibrillation
Radiofrequency Catheter Ablation for Atrial Fibrillation Background Atrial fibrillation (AP) is the commonest sustained arrhythmia. It affects around I% of the population, and its incidence is increasing.
More informationHybrid Ablation of AF in the Operating Room: Is There a Need? MAZE III Procedure. Spectrum of Atrial Fibrillation
Hybrid Ablation of AF in the Operating Room: Is There a Need? MAZE III Procedure Paul J. Wang, MD Amin Al-Ahmad, MD Gan Dunnington, MD Stanford University Cox J, et al. Ann Thorac Surg. 1993;55:578-580.
More informationDebate-STAR AF 2 study. PVI is not enough
Debate-STAR AF 2 study PVI is not enough Debate about STAR AF 2 trial STAR AF trial Substrate and Trigger Ablation for Reduction of Atrial Fibrillation EHJ 2010 STAR-AF 2 trial One Size Fits All? PVI is
More informationJournal of the American College of Cardiology Vol. 37, No. 2, by the American College of Cardiology ISSN /01/$20.
Journal of the American College of Cardiology Vol. 37, No. 2, 2001 2001 by the American College of Cardiology ISSN 0735-1097/01/$20.00 Published by Elsevier Science Inc. PII S0735-1097(00)01133-5 Coronary
More informationElectrogram-Guided Ablation
GRBQ381-3653G-C11[184-197].qxd 12/20/2007 07:45 PM Page 184 Aptara(PPG Quark) 11 Electrogram-Guided Ablation Evan Lockwood Koonlawee Nademanee In 1994, Swartz et al. (1) ushered in an era of incredible
More informationThe radial procedure was developed as an outgrowth
The Radial Procedure for Atrial Fibrillation Takashi Nitta, MD The radial procedure was developed as an outgrowth of an alternative to the maze procedure. The atrial incisions are designed to radiate from
More informationLinear Ablation Should Not Be a Standard Part of Ablation in Persistent AF. Disclosures. LA Ablation vs. Segmental Ostial Ablation With PVI for PAF
Linear Ablation Should Not Be a Standard Part of Ablation in Persistent AF The CA Heart Rhythm Symposium September 7, 2012 Gregory K. Feld, MD Professor of Medicine Director, Cardiac EP Program University
More informationCase Report Figure-8 Tachycardia Confined to the Anterior Wall of the Left Atrium
www.ipej.org 146 Case Report Figure-8 Tachycardia Confined to the Anterior Wall of the Left Atrium Ioan Liuba, M.D., Anders Jönsson, M.D., Håkan Walfridsson, M.D. Department of Cardiology, Heartcenter,
More information2017 HRS/EHRA/ECAS/APHRS/SOLAECE Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation
Summary of Expert Consensus Statement for CLINICIANS 2017 HRS/EHRA/ECAS/APHRS/SOLAECE Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation This is a summary of the Heart
More informationAtrial fibrillation (AF) is associated with increased morbidity
Ablation of Atrial Fibrillation with Concomitant Surgery Edward G. Soltesz, MD, MPH, and A. Marc Gillinov, MD Atrial fibrillation (AF) is associated with increased morbidity and mortality in coronary artery
More informationPeri-Mitral Atrial Flutter with Partial Conduction Block between Left Atrium and Coronary Sinus
Accepted Manuscript Peri-Mitral Atrial Flutter with Partial Conduction Block between Left Atrium and Coronary Sinus Ryota Isogai, MD, Seiichiro Matsuo, MD, Ryohsuke Narui, MD, Shingo Seki, MD;, Michihiro
More informationPrevalence of Asymptomatic Recurrences of Atrial Fibrillation After Successful Radiofrequency Catheter Ablation
920 Prevalence of Asymptomatic Recurrences of Atrial Fibrillation After Successful Radiofrequency Catheter Ablation HAKAN ORAL, M.D., SRIKAR VEERAREDDY, M.D., ERIC GOOD, D.O., BURR HALL, M.D., PETER CHEUNG,
More informationCatheter ablation of atrial fibrillation: Indications and tools for improvement of the success rate of the method. Konstantinos P.
Ioannina 2015 Catheter ablation of atrial fibrillation: Indications and tools for improvement of the success rate of the method Konstantinos P. Letsas, MD, FESC SECOND DEPARTMENT OF CARDIOLOGY LABORATORY
More informationPeri-mitral atrial flutter in patients with atrial fibrillation ablation
Peri-mitral atrial flutter in patients with atrial fibrillation ablation Seiichiro Matsuo, MD,* Matthew Wright, MBBS, PhD,* Sébastien Knecht, MD,* Isabelle Nault, MD,* Nicolas Lellouche, MD,* Kang-Teng
More informationΚατάλυση παροξυσμικής κολπικής μαρμαρυγής Ποια τεχνολογία και σε ποιους ασθενείς; Χάρης Κοσσυβάκης Καρδιολογικό Τμήμα Γ.Ν.Α. «Γ.
Κατάλυση παροξυσμικής κολπικής μαρμαρυγής Ποια τεχνολογία και σε ποιους ασθενείς; Χάρης Κοσσυβάκης Καρδιολογικό Τμήμα Γ.Ν.Α. «Γ. ΓΕΝΝΗΜΑΤΑΣ» Rhythm control antiarrhythmic drugs vs catheter ablation Summary
More informationRole of LAA isolation in AF cure
MAM 2017, Zurich Role of LAA isolation in AF cure Sakis Themistoclakis, MD Director, Unit of Electrophysiology and Cardiac Pacing Department of Cardiothoracic & Vascular Medicine Ospedale dell Angelo,
More informationOriginal Article Short- and long-term experience in pulmonary vein segmental ostial ablation for paroxysmal atrial fibrillation*
www.ipej.org 6 Original Article Short- and long-term experience in pulmonary vein segmental ostial ablation for paroxysmal atrial fibrillation* *English version of "Langzeit-Ergebnisse der ostialen Pulmonalvenenisolation
More informationElectrical disconnection of pulmonary vein (PV) myocardium
Left Atrial Appendage Activity Masquerading as Pulmonary Vein Potentials Dipen Shah, MD; Michel Haissaguerre, MD; Pierre Jais, MD; Meleze Hocini, MD; Teiichi Yamane, MD; Laurent Macle, MD; Kee Joon Choi,
More informationPulmonary Vein Isolation for the Treatment of Drug-Refractory Atrial Fibrillation in Adults with Congenital Heart Diseasechd_
392 Pulmonary Vein Isolation for the Treatment of Drug-Refractory Atrial Fibrillation in Adults with Congenital Heart Diseasechd_649 392..399 Femi Philip, MD,* Kamran I. Muhammad, MD,* Shikar Agarwal,
More informationA Randomized Trial of Circumferential Pulmonary Vein Ablation Versus Antiarrhythmic Drug Therapy in Paroxysmal Atrial Fibrillation
Journal of the American College of Cardiology Vol. 48, No. 11, 2006 2006 by the American College of Cardiology Foundation ISSN 0735-1097/06/$32.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2006.08.037
More informationMapping techniques in AFib. Helmut Pürerfellner, MD Public Hospital Elisabethinen Academic Teaching Hospital Linz, Austria
Mapping techniques in AFib Helmut Pürerfellner, MD Public Hospital Elisabethinen Academic Teaching Hospital Linz, Austria critical zone Microreeentrant circuits LOM PV foci Sueda Ann Thorac Surg 1997 Haissaguerre
More informationEvaluation of the Recurrence of Atrial Fibrillation After Pulmonary Venous Ablation
J Cardiol 22 Sep; 4 3 : 87 94 Evaluation of the Recurrence of Atrial Fibrillation After Pulmonary Venous Ablation Hideko Koichiro Hiroo Hideaki Tomoo Keijiro NAKASHIMA, MD KUMAGAI, MD, FJCC NOGUCHI, MD
More informationComparative Effectiveness of Radiofrequency Catheter Ablation for Atrial Fibrillation Executive Summary
Number 15 Effective Health Care Comparative Effectiveness of Radiofrequency Catheter Ablation for Atrial Fibrillation Executive Summary Background The Agency for Healthcare Research and Quality commissioned
More informationTehran Arrhythmia Center
Tehran Arrhythmia Center The Worst Scenario A 4 year old kid High heart rates first noted by parents at 20 months of age. Family physician detected rates as high as 220 bpm at that age. He was visited,
More informationElectrophysiological Characteristics of Atrial Tachycardia After Pulmonary Vein Isolation of Atrial Fibrillation
Circulation Journal Official Journal of the Japanese Circulation Society http://www.j-circ.or.jp Advance Publication by J-STAGE REVIEW Electrophysiological Characteristics of Atrial Tachycardia After Pulmonary
More informationRecent observations have focused attention on the PVs as a source of ectopic activity i determining i AF
Atrial Fibrillation in 2010 Panos Vardas Professor of Cardiology President of EHRA Atrial Fibrillation Pathophysiology of AF Triggers Recent observations have focused attention on the PVs as a source of
More informationHow to Distinguish Focal Atrial Tachycardia from Small Circuits and Reentry
How to Distinguish Focal Atrial Tachycardia from Small Circuits and Reentry Pierre Jaïs; Bordeaux, France IHU LIRYC ANR-10-IAHU-04 Equipex MUSIC imaging platform ANR-11-EQPX-0030 Eutraf HEALTH-F2-2010-261057
More informationAtrial Fibrillation Procedures Data Summary. Participant STS Period Ending 12/31/2016
Period Ending 12/31/2016 Number of Cases Preoperative Predominant Atrial Arrhythmia Type Paroxysmal Atrial Fibrillation... - - Persistent Atrial Fibrillation... - - Longstanding Persistent Atrial Fibrillation...
More informationCARDIOINSIGHT TM NONINVASIVE 3D MAPPING SYSTEM CLINICAL EVIDENCE SUMMARY
CARDIOINSIGHT TM NONINVASIVE 3D MAPPING SYSTEM CLINICAL EVIDENCE SUMMARY April 2017 SUPPORTING EVIDENCE RHYTHM AF VT PUBLICATIONS Driver Domains in Persistent Atrial Fibrillation (Haissaiguerre, et al)
More informationInterventional solutions for atrial fibrillation in patients with heart failure
Interventional solutions for atrial fibrillation in patients with heart failure Advances in Cardiovascular Arrhythmias Great Innovations in Cardiology Matteo Anselmino, MD PhD Division of Cardiology Department
More informationSupplementary Online Content
Supplementary Online Content Verma A, Champagne J, Sapp J, et al. Asymptomatic episodes of atrial fibrillation before and after catheter ablation: a prospective, multicenter study. JAMA Intern Med. Published
More informationRaphael Rosso MD, Yuval Levi Med. Eng., Sami Viskin MD Tel Aviv Sourasky Medical Center
Radiofrequency Ablation of Atrial Fibrillation: Comparison of Success Rate of Circular Ablation vs Point-by-Point Ablation with Contact Force Assessment in Paroxysmal and Persistent Atrial Fibrillation
More informationLong-Term Outcome and Risks of Catheter Ablation for Atrial Fibrillation
Long-Term Outcome and Risks of Catheter Ablation for Atrial Fibrillation Carlo Pappone, MD, PhD, FACC EP Director, Villa Maria Hospital Group How many times AF can increase mortality DO MORTALITY REALLY
More informationReversal of pulmonary vein remodeling after catheter ablation of atrial fibrillation
Journal of Geriatric Cardiology (2016) 13: 163 168 2016 JGC All rights reserved; www.jgc301.com Research Article Open Access Reversal of pulmonary vein remodeling after catheter ablation of atrial fibrillation
More informationCatheter Ablation for Atrial Fibrillation: Patient Selection and Outcomes
Catheter Ablation for Atrial Fibrillation: Patient Selection and Outcomes Francis Marchlinski, MD Richard T and Angela Clark President s Distinguished Professor Director Cardiac Electrophysiolgy University
More informationCase 1 Left Atrial Tachycardia
Case 1 Left Atrial Tachycardia A 16 years old woman was referred to our institution because of recurrent episodes of palpitations and dizziness despite previous ablation procedure( 13 years ago) of postero-septal
More informationCatheter ablation techniques in managing arrhythmias
THEME Arrhythmias Peter M Kistler MBBS, PhD, FRACP, is a cardiologist and electrophysiologist, Department of Cardiology, The Alfred Hospital, and Department of Clinical Electrophysiology Research, The
More informationAtrial Fibrillation and Common Supraventricular Tachycardias. Sunil Kapur MD
Atrial Fibrillation and Common Supraventricular Tachycardias Sunil Kapur MD Cardiac Electrophysiology Brigham and Women s Hospital Instructor, Harvard Medical School No disclosures Cardiac Conduction:
More informationEvidence for Longitudinal and Transverse Fiber Conduction in Human Pulmonary Veins
Evidence for Longitudinal and Transverse Fiber Conduction in Human Pulmonary Veins Relevance for Catheter Ablation Javier E. Sanchez, MD; Vance J. Plumb, MD; Andrew E. Epstein, MD; G. Neal Kay, MD Background
More informationCase Report Successful Multi-chamber Catheter Ablation of Persistent Atrial Fibrillation in Cor Triatriatum Sinister
www.ipej.org 50 Case Report Successful Multi-chamber Catheter Ablation of Persistent Atrial Fibrillation in Cor Triatriatum Sinister Andrew Gavin, MBChB 1, Cameron B Singleton, MD 1, Andrew D McGavigan,
More informationEmergency Medical Training Services Emergency Medical Technician Paramedic Program Outlines Outline Topic: WPW Revised: 11/2013
Emergency Medical Training Services Emergency Medical Technician Paramedic Program Outlines Outline Topic: WPW Revised: 11/2013 Wolff-Parkinson-White syndrome (WPW) is a syndrome of pre-excitation of the
More informationCardiac Arrhythmias. Cathy Percival, RN, FALU, FLMI VP, Medical Director AIG Life and Retirement Company
Cardiac Arrhythmias Cathy Percival, RN, FALU, FLMI VP, Medical Director AIG Life and Retirement Company The Cardiovascular System Three primary functions Transport of oxygen, nutrients, and hormones to
More informationRuolo della ablazione della fibrillazione atriale nello scompenso cardiaco
Ruolo della ablazione della fibrillazione atriale nello scompenso cardiaco Matteo Anselmino Division of Cardiology Città della Salute e della Scienza Hospital University of Turin, Italy Disclosure: Honoraria
More informationUniversity of Groningen. Ablation of atrial fibrillation de Maat, Gijs Eduard
University of Groningen Ablation of atrial fibrillation de Maat, Gijs Eduard IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from it. Please check
More informationAtrial Fibrillation New Approaches, Techniques, and Technology
New Cardiovascular Horizons 2015 May 28, 2015 New Orleans, Louisiana Atrial Fibrillation New Approaches, Techniques, and Technology State of the Art - - 2015 Richard Abben, M D Director, Cardiac Arrhythmia
More information